by [email protected] | Feb 14, 2023 | immunology, Publication
Abstract Objective: Assess healthcare costs associated with systemic lupus erythematosus (SLE) flares among patients with and without lupus nephritis (LN). Methods: This retrospective cohort study used medical and pharmacy claims data from the United...
by [email protected] | Feb 10, 2023 | News & Events
STATinMED is thrilled to announce our Exhibit presence (Booth 2032) at the Annual Academy of Managed Care Pharmacy (AMCP) Annual Meeting to be held in San Antonio, TX, March 21-24, 2023. Hope to see you there! Poster presentations The economic burden of comorbid...
by [email protected] | Jan 13, 2023 | Cardiovascular, Publication
Abstract Background: In the USA, there is a steady rise of atrial fibrillation due to the aging population with increased morbidity. This study evaluated the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) among elderly patients with...
by [email protected] | Jan 4, 2023 | Blog
STATinMED at ASH 2022 64th Annual ASH Meeting & Exposition: Dec 10-13, 2022, New Orleans, LA Presentations Oral Presentation: National view of prevalent and newly-diagnosed patients with multiple myeloma in 2021: A retrospective analysis of national...
by [email protected] | Dec 20, 2022 | Blog
Our Vice President, Real-World Evidence (RWE) shares her perspective about HEOR, RWD, evidence generation, and more. (First in a 2-part series) What is the current landscape for pharmaceutical and biotechnology products? It is an exciting time. I’ve spent 30 years in...
